Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap)  (beta) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer) Overgo Probe Designer
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:hydroxyisoflavans
go back to main search page
Accession:CHEBI:76250 term browser browse the term
Definition:A member of the class of isoflavans in which one or more ring hydrogens are replaced by hydroxy groups.


show annotations for term's descendants           Sort by:
equol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Afp alpha-fetoprotein affects binding EXP Equol binds to AFP protein CTD PMID:23013281 PMID:25349334 NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 increases phosphorylation ISO Equol results in increased phosphorylation of AKT1 protein CTD PMID:16840783 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G Alpg alkaline phosphatase, germ cell increases expression ISO Equol results in increased expression of ALPG mRNA CTD PMID:15993745 NCBI chr 9:87,748,721...87,761,500
Ensembl chr 9:87,753,648...87,757,836 		JBrowse link
G Ar androgen receptor affects binding EXP Equol binds to AR protein CTD PMID:14565775 NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:63,104,771...63,273,925 		JBrowse link
G Casp3 caspase 3 increases activity ISO Equol results in increased activity of CASP3 protein CTD PMID:18973749 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp6 caspase 6 increases cleavage ISO Equol results in increased cleavage of CASP6 protein CTD PMID:18973749 NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502 		JBrowse link
G Casp7 caspase 7 increases cleavage ISO Equol results in increased cleavage of CASP7 protein CTD PMID:18973749 NCBI chr 1:255,437,195...255,476,737
Ensembl chr 1:255,437,172...255,476,729 		JBrowse link
G Casp9 caspase 9 increases cleavage ISO Equol results in increased cleavage of CASP9 protein CTD PMID:18973749 NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626 		JBrowse link
G Cav1 caveolin 1 multiple interactions ISO Equol inhibits the reaction [NOS3 protein binds to CAV1 protein] CTD PMID:16840783 NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705 		JBrowse link
G Ccna2 cyclin A2 decreases expression ISO Equol results in decreased expression of CCNA2 mRNA CTD PMID:16865672 NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577 		JBrowse link
G Ccnb2 cyclin B2 decreases expression ISO Equol results in decreased expression of CCNB2 mRNA CTD PMID:16865672 NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874 		JBrowse link
G Cd86 CD86 molecule multiple interactions ISO Equol inhibits the reaction [Lipopolysaccharides results in increased expression of CD86 protein] CTD PMID:21945492 NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818 		JBrowse link
G Cdc25b cell division cycle 25B decreases expression ISO Equol results in decreased expression of CDC25B mRNA CTD PMID:16865672 NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272 		JBrowse link
G Cdc25c cell division cycle 25C decreases expression ISO Equol results in decreased expression of CDC25C mRNA CTD PMID:16865672 NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185 		JBrowse link
G Cga glycoprotein hormones, alpha polypeptide decreases expression EXP Equol results in decreased expression of CGA mRNA CTD PMID:23220561 NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191 		JBrowse link
G Chek1 checkpoint kinase 1 decreases expression ISO Equol results in decreased expression of CHEK1 mRNA CTD PMID:16865672 NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009 		JBrowse link
G Cycs cytochrome c, somatic affects localization ISO Equol affects the localization of CYCS protein CTD PMID:18973749 NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 		JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 decreases expression ISO Equol results in decreased expression of CYP11A1 mRNA CTD PMID:26876617 NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 decreases expression ISO Equol results in decreased expression of CYP17A1 mRNA CTD PMID:26876617 NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 decreases expression ISO Equol results in decreased expression of CYP19A1 mRNA CTD PMID:26876617 NCBI chr 8:54,553,165...54,580,758
Ensembl chr 8:54,553,165...54,580,758 		JBrowse link
G Dbf4 DBF4 zinc finger decreases expression ISO Equol results in decreased expression of DBF4 mRNA CTD PMID:16865672 NCBI chr 4:25,676,570...25,701,152
Ensembl chr 4:25,676,634...25,701,066 		JBrowse link
G Dffa DNA fragmentation factor subunit alpha increases activity ISO Equol results in increased activity of DFFA protein CTD PMID:18973749 NCBI chr 5:159,540,718...159,553,639
Ensembl chr 5:159,540,715...159,553,633 		JBrowse link
G Dusp4 dual specificity phosphatase 4 decreases expression ISO Equol results in decreased expression of DUSP4 mRNA CTD PMID:16865672 NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138 		JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO [RTKI cpd results in decreased activity of EGFR protein] inhibits the reaction [Equol results in increased chemical synthesis of Oxygen]; [RTKI cpd results in decreased activity of EGFR protein] inhibits the reaction [Equol results in increased phosphorylation of and results in increased activity of NOS3 protein]; [RTKI cpd results in decreased activity of EGFR protein] inhibits the reaction [Equol results in increased phosphorylation of MAPK1 protein]; [RTKI cpd results in decreased activity of EGFR protein] inhibits the reaction [Equol results in increased phosphorylation of MAPK3 protein] CTD PMID:21300668 NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions
increases expression
increases activity
affects binding		 ISO
EXP		 [afimoxifene binds to and results in decreased activity of ESR1 protein] which results in decreased susceptibility to Equol; [fulvestrant binds to and results in decreased activity of ESR1 protein] which results in decreased susceptibility to Equol; Equol binds to and results in increased activity of ESR1 protein; Estradiol affects the reaction [Equol affects the activity of ESR1 protein]
Equol results in increased expression of ESR1 mRNA; Equol results in increased expression of ESR1 mRNA alternative form
Equol results in increased activity of ESR1 protein
Equol binds to ESR1 protein		 CTD PMID:15876408 PMID:15993745 PMID:16118406 PMID:16965913 PMID:19427779 More... NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002 		JBrowse link
G Esr2 estrogen receptor 2 multiple interactions
increases activity
affects binding		 ISO Equol binds to and results in increased activity of ESR2 protein; Equol inhibits the reaction [KAT5 protein results in decreased activity of ESR2 protein]; Equol inhibits the reaction [KAT5 protein results in increased activity of ESR2 protein]; Estradiol affects the reaction [Equol affects the activity of ESR2 protein]
Equol results in increased activity of ESR2 protein
Equol binds to ESR2 protein		 CTD PMID:12224631 PMID:15084758 PMID:15993745 PMID:16118406 PMID:16965913 More... NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919 		JBrowse link
G Gnrhr gonadotropin releasing hormone receptor decreases expression EXP Equol results in decreased expression of GNRHR mRNA CTD PMID:23220561 NCBI chr14:21,856,871...21,874,861
Ensembl chr14:21,856,871...21,874,861 		JBrowse link
G Igf1r insulin-like growth factor 1 receptor decreases expression ISO Equol results in decreased expression of IGF1R mRNA CTD PMID:16865672 NCBI chr 1:121,549,839...121,838,545
Ensembl chr 1:121,550,743...121,831,777 		JBrowse link
G Il4 interleukin 4 increases expression ISO Equol results in increased expression of IL4 mRNA; Equol results in increased expression of IL4 protein CTD PMID:16108819 NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750 		JBrowse link
G Kat5 lysine acetyltransferase 5 multiple interactions ISO Equol inhibits the reaction [KAT5 protein results in decreased activity of ESR2 protein]; Equol inhibits the reaction [KAT5 protein results in increased activity of ESR2 protein] CTD PMID:23857583 NCBI chr 1:202,895,751...202,903,178
Ensembl chr 1:202,895,751...202,903,458 		JBrowse link
G Lhb luteinizing hormone subunit beta decreases expression EXP Equol results in decreased expression of LHB protein CTD PMID:23220561 NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972
Ensembl chr 1:95,900,984...95,901,972 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
increases phosphorylation		 ISO [AG 1879 results in decreased activity of SRC protein] inhibits the reaction [Equol results in increased phosphorylation of MAPK1 protein]; [RTKI cpd results in decreased activity of EGFR protein] inhibits the reaction [Equol results in increased phosphorylation of MAPK1 protein]; [U 0126 results in decreased phosphorylation of [MAPK1 protein co-treated with MAPK3 protein]] which results in decreased susceptibility to Equol; AG 1879 inhibits the reaction [Equol results in increased phosphorylation of MAPK1 protein]; Equol results in increased activity of and results in increased phosphorylation of MAPK1 protein; Pertussis Toxin inhibits the reaction [Equol results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Equol results in increased activity of and results in increased phosphorylation of MAPK1 protein] CTD PMID:16840783 PMID:19427779 PMID:21300668 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
increases phosphorylation		 ISO [AG 1879 results in decreased activity of SRC protein] inhibits the reaction [Equol results in increased phosphorylation of MAPK3 protein]; [RTKI cpd results in decreased activity of EGFR protein] inhibits the reaction [Equol results in increased phosphorylation of MAPK3 protein]; [U 0126 results in decreased phosphorylation of [MAPK1 protein co-treated with MAPK3 protein]] which results in decreased susceptibility to Equol; AG 1879 inhibits the reaction [Equol results in increased phosphorylation of MAPK3 protein]; Equol results in increased activity of and results in increased phosphorylation of MAPK3 protein; Pertussis Toxin inhibits the reaction [Equol results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Equol results in increased activity of and results in increased phosphorylation of MAPK3 protein] CTD PMID:16840783 PMID:19427779 PMID:21300668 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Mcm4 minichromosome maintenance complex component 4 decreases expression ISO Equol results in decreased expression of MCM4 mRNA CTD PMID:16865672 NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144 		JBrowse link
G Me1 malic enzyme 1 increases expression ISO Equol results in increased expression of ME1 mRNA CTD PMID:16865672 NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304 		JBrowse link
G Nkx3-1 NK3 homeobox 1 decreases expression ISO Equol results in decreased expression of NKX3-1 mRNA CTD PMID:16865672 NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441 		JBrowse link
G Nos3 nitric oxide synthase 3 multiple interactions ISO [AG 1879 results in decreased activity of SRC protein] inhibits the reaction [Equol results in increased activity of and results in increased phosphorylation of NOS3 protein]; [Equol results in increased chemical synthesis of Superoxides] which results in increased activity of and results in increased phosphorylation of NOS3 protein; [RTKI cpd results in decreased activity of EGFR protein] inhibits the reaction [Equol results in increased phosphorylation of and results in increased activity of NOS3 protein]; Equol inhibits the reaction [NOS3 protein binds to CAV1 protein]; Equol results in increased activity of and results in increased phosphorylation of NOS3 protein; Equol results in increased phosphorylation of and results in increased activity of NOS3 protein; Manganese inhibits the reaction [Equol results in increased activity of and results in increased phosphorylation of NOS3 protein]; Pertussis Toxin inhibits the reaction [Equol results in increased activity of and results in increased phosphorylation of NOS3 protein]; Rotenone inhibits the reaction [Equol results in increased phosphorylation of and results in increased activity of NOS3 protein]; tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [[Equol results in increased chemical synthesis of Superoxides] which results in increased phosphorylation of NOS3 protein] CTD PMID:16840783 PMID:21300668 NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166 		JBrowse link
G Prim2 DNA primase subunit 2 decreases expression ISO Equol results in decreased expression of PRIM2 mRNA CTD PMID:16865672 NCBI chr 9:35,692,376...35,904,521
Ensembl chr 9:35,692,376...35,903,030 		JBrowse link
G Prl prolactin increases expression EXP Equol results in increased expression of PRL protein CTD PMID:23220561 NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO Equol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]; Equol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] CTD PMID:16870006 NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Shbg sex hormone binding globulin affects binding ISO Equol binds to SHBG protein CTD PMID:25349334 NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057 		JBrowse link
G Src SRC proto-oncogene, non-receptor tyrosine kinase multiple interactions ISO [AG 1879 results in decreased activity of SRC protein] inhibits the reaction [Equol results in increased activity of and results in increased phosphorylation of NOS3 protein]; [AG 1879 results in decreased activity of SRC protein] inhibits the reaction [Equol results in increased phosphorylation of MAPK1 protein]; [AG 1879 results in decreased activity of SRC protein] inhibits the reaction [Equol results in increased phosphorylation of MAPK3 protein] CTD PMID:21300668 NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476 		JBrowse link
G Stk39 serine threonine kinase 39 decreases expression ISO Equol results in decreased expression of STK39 mRNA CTD PMID:16865672 NCBI chr 3:52,913,583...53,179,060
Ensembl chr 3:52,913,585...53,179,060 		JBrowse link
G Tff1 trefoil factor 1 increases expression ISO Equol results in increased expression of TFF1 mRNA CTD PMID:16965913 NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597 		JBrowse link
G Thbs1 thrombospondin 1 decreases expression ISO Equol results in decreased expression of THBS1 mRNA CTD PMID:16865672 NCBI chr 3:105,056,286...105,071,445
Ensembl chr 3:105,056,292...105,071,440 		JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 increases glucuronidation ISO UGT1A1 protein results in increased glucuronidation of Equol CTD PMID:14557274 NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465 		JBrowse link
G Ugt1a8 UDP glucuronosyltransferase family 1 member A8 increases glucuronidation ISO UGT1A8 protein results in increased glucuronidation of Equol CTD PMID:14557274 NCBI chr 9:88,727,094...88,808,465
Ensembl chr 9:88,713,184...88,808,465 		JBrowse link
G Ugt1a9 UDP glucuronosyltransferase family 1 member A9 increases glucuronidation ISO UGT1A9 protein results in increased glucuronidation of Equol CTD PMID:14557274 NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465 		JBrowse link
G Ugt2b1 UDP glucuronosyltransferase 2 family, polypeptide B1 increases expression ISO Equol results in increased expression of UGT2B17 mRNA CTD PMID:16865672 NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986 		JBrowse link
glabridin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions ISO [glabridin affects the activity of ABCB1 protein] which results in increased abundance of Daunorubicin CTD PMID:18204840 NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Casp8 caspase 8 increases cleavage ISO glabridin results in increased cleavage of CASP8 protein CTD PMID:29663662 NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542 		JBrowse link
G Casp9 caspase 9 increases cleavage ISO glabridin results in increased cleavage of CASP9 protein CTD PMID:29663662 NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626 		JBrowse link
G Cycs cytochrome c, somatic multiple interactions ISO glabridin inhibits the reaction [Antimycin A affects the localization of CYCS protein] CTD PMID:21621525 NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 increases phosphorylation ISO glabridin results in increased phosphorylation of MAPK1 protein CTD PMID:29663662 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 increases phosphorylation ISO glabridin results in increased phosphorylation of MAPK3 protein CTD PMID:29663662 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases cleavage ISO glabridin results in increased cleavage of PARP1 protein CTD PMID:29663662 NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404 		JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 increases glucuronidation ISO UGT1A1 protein results in increased glucuronidation of glabridin CTD PMID:25765239 NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465 		JBrowse link
G Ugt1a2 UDP glucuronosyltransferase 1 family, polypeptide A2 increases glucuronidation ISO UGT1A3 protein results in increased glucuronidation of glabridin CTD PMID:25765239 NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465 		JBrowse link
G Ugt1a8 UDP glucuronosyltransferase family 1 member A8 increases glucuronidation ISO UGT1A8 protein results in increased glucuronidation of glabridin CTD PMID:25765239 NCBI chr 9:88,727,094...88,808,465
Ensembl chr 9:88,713,184...88,808,465 		JBrowse link
G Ugt1a9 UDP glucuronosyltransferase family 1 member A9 increases glucuronidation ISO UGT1A9 protein results in increased glucuronidation of glabridin CTD PMID:25765239 NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465 		JBrowse link
G Ugt2b7 UDP glucuronosyltransferase family 2 member B7 increases glucuronidation ISO UGT2B7 protein results in increased glucuronidation of glabridin CTD PMID:25765239 NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604 		JBrowse link
glycyrin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Dyrk1a dual specificity tyrosine phosphorylation regulated kinase 1A decreases activity ISO glycyrin results in decreased activity of DYRK1A protein CTD PMID:31838052 NCBI chr11:33,890,706...34,009,420
Ensembl chr11:33,890,490...34,009,420 		JBrowse link
licoricidin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 AKT serine/threonine kinase 1 multiple interactions
decreases phosphorylation		 ISO [Gemcitabine co-treated with licoricidin] results in decreased phosphorylation of AKT1 protein; [licoricidin co-treated with Gemcitabine] results in decreased phosphorylation of AKT1 protein
licoricidin results in decreased phosphorylation of AKT1 protein		 CTD PMID:29782821 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G Casp3 caspase 3 multiple interactions
increases activity		 ISO licoricidin promotes the reaction [Gemcitabine results in increased activity of CASP3 protein]; licoricidin promotes the reaction [Gemcitabine results in increased expression of and results in increased activity of CASP3 protein]; licoricidin results in increased expression of and results in increased activity of CASP3 protein
licoricidin results in increased activity of CASP3 protein		 CTD PMID:29782821 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions
decreases phosphorylation		 ISO licoricidin inhibits the reaction [Gemcitabine results in increased phosphorylation of RELA protein]
licoricidin results in decreased phosphorylation of RELA protein		 CTD PMID:29782821 NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19818
    chemical entity 19816
      molecular entity 19816
        polyatomic entity 19774
          heteroatomic molecular entity 19728
            hydroxides 19312
              organic hydroxy compound 18933
                hydroxyisoflavans 56
                  (-)-phaseollinisoflavan + 0
                  (-)-sativan 0
                  (-)-vestitol 0
                  (3R)-7,2'-dihydroxy-3',4'-dimethoxyisoflavan-7-O-beta-D-glucopyranoside 0
                  (3R)-7,2'-dihydroxy-4'-methoxyisoflavanol + 0
                  (3R,4R)-2'-hydroxy-4',5'-methylenedioxyisoflavan-4,7-diol 0
                  (3R,4R)-4,2'-dihydroxyisoflavans + 0
                  (3R,4R)-7,2',4'-trihydroxyisoflavanol 0
                  (3S,4R)-4' hydroxy-6,3' dimethoxyisoflavan-4-ol 0
                  (4R)-4,2'-Dihydroxyisoflavan 0
                  (R)-2',4',7-Trihydroxy-3',8-diprenylisoflavan 0
                  (R)-Equol 0
                  2'-O-methylphaseollinisoflavan 0
                  3',4',7-Trihydroxyisoflavan 0
                  3'-Hydroxyequol 0
                  3-(2,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4,6,7-triol 0
                  3-(4-Hydroxyphenyl)chroman-7-ol 0
                  3-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-6,7-diol 0
                  7,2'-dihydroxy-4'-methoxyisoflavanol + 0
                  Austalide K 0
                  Austalide L 0
                  Cyclomillinol 0
                  Demethylvestitol 0
                  Ohioensin-A 0
                  Phomoarcherin A 0
                  Phomoarcherin B 0
                  Phomoarcherin C 0
                  [4-(7-hydroxy-3,4-dihydro-2H-1-benzopyran-3-yl)phenyl]oxidanesulfonic acid 0
                  cis-4-Hydroxyequol 0
                  conferol A 0
                  conferol B 0
                  equol 49
                  glabridin 12
                  glyasperin C 0
                  glyasperin D 0
                  glycyrin 1
                  hispaglabridin A 0
                  kampanol A 0
                  licoricidin + 3
                  licorisoflavan A 0
                  lotisoflavan 0
                  mucronulatol 0
                  torvanol A hydrogen sulfate 0
                  vestitol + 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19818
    subatomic particle 19816
      composite particle 19816
        hadron 19816
          baryon 19816
            nucleon 19816
              atomic nucleus 19816
                atom 19816
                  main group element atom 19761
                    p-block element atom 19761
                      carbon group element atom 19703
                        carbon atom 19698
                          organic molecular entity 19698
                            organic molecule 19656
                              organic cyclic compound 19461
                                organic heterocyclic compound 18817
                                  oxacycle 17770
                                    benzopyran 11699
                                      1-benzopyran 11461
                                        isoflavonoid 3794
                                          isoflavans 129
                                            hydroxyisoflavans 56
                                              (-)-phaseollinisoflavan + 0
                                              (-)-sativan 0
                                              (-)-vestitol 0
                                              (3R)-7,2'-dihydroxy-3',4'-dimethoxyisoflavan-7-O-beta-D-glucopyranoside 0
                                              (3R)-7,2'-dihydroxy-4'-methoxyisoflavanol + 0
                                              (3R,4R)-2'-hydroxy-4',5'-methylenedioxyisoflavan-4,7-diol 0
                                              (3R,4R)-4,2'-dihydroxyisoflavans + 0
                                              (3R,4R)-7,2',4'-trihydroxyisoflavanol 0
                                              (3S,4R)-4' hydroxy-6,3' dimethoxyisoflavan-4-ol 0
                                              (4R)-4,2'-Dihydroxyisoflavan 0
                                              (R)-2',4',7-Trihydroxy-3',8-diprenylisoflavan 0
                                              (R)-Equol 0
                                              2'-O-methylphaseollinisoflavan 0
                                              3',4',7-Trihydroxyisoflavan 0
                                              3'-Hydroxyequol 0
                                              3-(2,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4,6,7-triol 0
                                              3-(4-Hydroxyphenyl)chroman-7-ol 0
                                              3-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-6,7-diol 0
                                              7,2'-dihydroxy-4'-methoxyisoflavanol + 0
                                              Austalide K 0
                                              Austalide L 0
                                              Cyclomillinol 0
                                              Demethylvestitol 0
                                              Ohioensin-A 0
                                              Phomoarcherin A 0
                                              Phomoarcherin B 0
                                              Phomoarcherin C 0
                                              [4-(7-hydroxy-3,4-dihydro-2H-1-benzopyran-3-yl)phenyl]oxidanesulfonic acid 0
                                              cis-4-Hydroxyequol 0
                                              conferol A 0
                                              conferol B 0
                                              equol 49
                                              glabridin 12
                                              glyasperin C 0
                                              glyasperin D 0
                                              glycyrin 1
                                              hispaglabridin A 0
                                              kampanol A 0
                                              licoricidin + 3
                                              licorisoflavan A 0
                                              lotisoflavan 0
                                              mucronulatol 0
                                              torvanol A hydrogen sulfate 0
                                              vestitol + 0
paths to the root